Universitätsklinikum Jena

Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses (2016) Kleiter I, Gahlen A, Borisow N, Fischer K, Wernecke KD, Wegner B, Hellwig K, et al. Journal article Pseudo-HE images derived from CARS/TPEF/SHG multimodal imaging in combination with Raman-spectroscopy as a pathological screening tool (2016) Bocklitz TW, Salah FS, Vogler N, Heuke S, Chernavskaia O, Schmidt C, Waldner M, et al. Journal article Bayesian Cure Rate Modeling of Local Tumor Control: Evaluation in Stereotactic Body Radiation Therapy for Pulmonary Metastases (2016) Klement RJ, Allgaeuer M, Andratschke N, Blanck O, Boda-Heggemann J, Dieckmann K, Duma M, et al. Journal article Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy (2016) Guckenberger M, Klement RJ, Allgaeuer M, Andratschke N, Blanck O, Boda-Heggemann J, Dieckmann K, et al. Journal article Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial (2016) Ferreri AJM, Cwynarski K, Pulczynski E, Ponzoni M, Deckert M, Politi LS, Torri V, et al. Journal article Acid sphingomyelinase promotes endothelial stress response in systemic inflammation and sepsis (2016) Chung HY, Hupe DC, Otto GP, Sprenger M, Bunck AC, Dorer MJ, Bockmeyer CL, et al. Journal article Seasonal Variation in Blood Pressure in 162,135 Patients With Type 1 or Type 2 Diabetes Mellitus (2016) Hermann JM, Rosenbauer J, Dost A, Steigleder-Schweiger C, Kiess W, Schöfl C, Holl RW Journal article Overwhelming Postsplenectomy Infection: A Prospective Multicenter Cohort Study (2016) Theilacker C, Ludewig K, Serr A, Schimpf J, Held J, Boegelein M, Bahr V, et al. Journal article Tumour stage distribution and survival of malignant melanoma in Germany 2002-2011 (2016) Schoffer O, Schuelein S, Arand G, Arnholdt H, Baaske D, Bargou RC, Becker N, et al. Journal article Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational study (2016) Stallmach A, Langbein C, Atreya R, Bruns T, Dignass A, Ende K, Hampe J, et al. Journal article